Skip to content
healthcare.dev

Flexbumin

NDC 0944-0495, Albumin Human, injection, solution, from Takeda Pharmaceuticals America, Inc..

Product NDC
0944-0495
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA101452
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0944-0495 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALBUMIN HUMAN.05 g/mL

Pharmacologic classes

Human Serum Albumin [EPC]; Increased Intravascular Volume [PE]; Increased Oncotic Pressure [PE]; Osmotic Activity [MoA]; Serum Albumin [Chemical/Ingredient]

Package NDCNDC-11Package
0944-0495-05009440495052 BAG in 1 CARTON (0944-0495-05) / 250 mL in 1 BAG (0944-0495-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0944-0495 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0944-0495 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0944-0495. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.